5 Dumbest Things on...
Health Care: Drugs
Delcath Systems Inc. (DCTH: NASDAQ)
$0.41 -0.01 | -3.39%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.41 |
| 52 Week High | 2.38 |
| 52 Week Low | 0.38 |
| Avg. Daily Vol. (Mil) | 3.30 |
| Beta (3 year) | 2.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 39.72 |
| Shares Out (Mil) | 96.73 |
| Float (Mil) | 95.69 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.90 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 54.70 |
| Price/Book | 1.03 |
| Price/Cash Flow | -0.60 |
| Per Share Data | |
| Earnings | -0.72 |
| Sales | 0.01 |
| Book Value | 0.40 |
| Cash Flow | -0.66 |
| Business Summary | |
|---|---|
| Delcath Systems, Inc., is a pharmaceutical and medical device company. It focuses on the treatment of primary and metastatic liver cancers. | |
| General Information | |
| 810 Seventh Avenue
35th Floor New York, NY 10019 |
|
| www.delcath.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 92 | |
| CEO: Eamonn P. Hobbs | |
| Short Interest | |
| Current Month (Mil) | 10.73 |
| Previous Month (Mil) | 9.57 |
| Short Interest Ratio (Days) | 3.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -130.70 |
| Return on Investments | -168.00 |
| Profitability | |
| Gross Margin | 90.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with DCTH
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserROSIE
Latest DCTH Headlines from TheStreet
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Leaders of TheStreet's Drug Approval Contest 05.06.13 | 09:05 am
- Stock Futures Eye Rebound on ECB Stimulus, U.S. Data 05.02.13 | 08:05 am
- Aveo, Delcath FDA Panel Live Blog 05.02.13 | 07:05 am
- FDA Tells Delcath No Approval Without New Clinical Trial 04.30.13 | 10:04 am
- Prepping for Aveo, Delcath FDA Panels 04.29.13 | 02:04 pm
- Biotech's Next Big Thing: Aveo
04.25.13 | 09:04 am - Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm 03.15.13 | 06:03 am
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
Press Releases for DCTH
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm - PR Newswire 05.18.13 | 09:05 am
- Delcath Systems, Inc. Sued By Investor - PR Newswire 05.10.13 | 07:05 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Delcath Systems, Inc. - PR Newswire 05.03.13 | 08:05 am
- Delcath To Present At JMP Securities Healthcare Conference On July 12 - PR Newswire 07.09.12 | 04:07 pm
- Delcath Announces First CHEMOSAT Procedures In Germany - PR Newswire 02.27.12 | 06:02 am
- Delcath Announces Updated Efficacy Results From Phase 3 Trial Of Chemosaturation For Melanoma Metastases In The Liver Presented At European Multidisciplinary Cancer Congress - PR Newswire 09.23.11 | 06:09 pm
- Positive Phase 2 Trial Results From Neuroendocrine Tumor Cohort Presented At CIRSE - PR Newswire 09.13.11 | 02:09 am
- Delcath Systems Receives Refusal To File Letter From FDA - PR Newswire 02.22.11 | 05:02 am
- Delcath Achieves ISO 13485 Certification - PR Newswire 02.17.11 | 09:02 am
- Delcath Completes New Drug Application Submission To The FDA For The Chemosaturation Delivery System - PR Newswire 12.22.10 | 07:12 am
Partner Headlines for DCTH
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Morning Market Losers - Benzinga 10.15.12 | 09:10 am
- Benzinga's Microcap Movers for Friday October 5, 2012 - Benzinga 10.06.12 | 06:10 pm
- Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst - Seeking Alpha 09.28.12 | 09:09 am
- Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO - GuruFocus 06.11.12 | 01:06 pm
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Hyper-Novel Investments For Targeting Cancer - Seeking Alpha 05.30.12 | 09:05 am
- Mid-Day Update: Stocks Trending Water Ahead of First Holiday Weekend of Summer - NASDAQ 05.25.12 | 04:05 pm
- Mid-Day Market Losers - Benzinga 05.25.12 | 01:05 pm
- 4 Stocks Attracting Heavy Trading Interest - Wall St. Cheat Sheet 05.25.12 | 12:05 pm
